The need to develop a clinical practice guideline for the assessment and management of increased intestinal permeability (IP Guideline) was identified after health services research revealed gaps in both the published literature and clinical practice. This clinical practice guideline serves as the first guideline for increased intestinal permeability as no guideline surrounding any part of the assessment or management of increased intestinal permeability has been developed in Australia or internationally. The guideline project will commence in July 2020.
Aim and objectives
The IP Guideline aims to improve the management of increased intestinal permeability by clinicians in private practice of Australia. The IP Guideline will provide clinicians with evidence-based recommendations for the treatment of increased intestinal permeability.
In order to facilitate a transparent and evidence-based clinical practice guideline, the IP Guideline should publicly display key documents. Below are the clinical question that will be asked to support the development of key recommendations. Feedback and suggestions are welcome from clinicians, patients with increased intestinal permeability or any other stakeholder involved in the assessment or management of increased intestinal permeability in Australian adults. Contact us now!
Leech, B, McIntyre, E, Steel, A, Sibbritt, D 2021, “The Subjective Well-being and Health-Related Quality of Life of Australian Adults with Increased Intestinal Permeability and Associations with Treatment Interventions”, The Journal of Alternative and Complementary Medicine, InPress.
Leech, B, McIntyre, E, Steel, A, Sibbritt, D 2022, “Health-seeking behaviour, views and preferences of adults with suspected increased intestinal permeability: A cross-sectional survey of Australian adults”, Integrative Medicine Research, Vol 11, (1)